INKT
MiNK Therapeutics (INKT)
$04
About MiNK Therapeutics (INKT)
MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.
Details
Daily high
$11.38
Daily low
$11.00
Price at open
$11.00
52 Week High
$76.00
52 Week Low
$6.34
Market cap
55.6M
Dividend yield
0.00%
Volume
8,396
Avg. volume
46,996
P/E ratio
-3.77
MiNK Therapeutics News
Details
Daily high
$11.38
Daily low
$11.00
Price at open
$11.00
52 Week High
$76.00
52 Week Low
$6.34
Market cap
55.6M
Dividend yield
0.00%
Volume
8,396
Avg. volume
46,996
P/E ratio
-3.77